Lv3
208 积分 2021-12-13 加入
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
2个月前
已完结
Acute myeloid leukaemia
4个月前
已完结
Acute myeloid leukaemia
4个月前
已完结
Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology
4个月前
已完结
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs
7个月前
已完结
Experience with ponatinib in paediatric patients with leukaemia
7个月前
已完结
Ponatinib in pediatric patients with Philadelphia chromosome-positive leukemia: a retrospective survey of the Japan Children’s Cancer Group
7个月前
已完结
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial
7个月前
已完结
Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
7个月前
已完结
Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome‐positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL‐94, ALL‐99 and ALL‐2005
7个月前
已完结
皖公网安备34019202002308
